Literature DB >> 16110474

Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism.

Davanea Forbes1, Mark Jackman, Amy Bishop, Mark Thomas, Ravi Kambadur, Mridula Sharma.   

Abstract

Myostatin, a secreted growth factor, is a member of the TGF-beta superfamily and an inhibitor of myogenesis. Previously, we have shown that myostatin gene expression is regulated at the level of transcription and that myostatin is a downstream target gene of MyoD. Here we show that myostatin gene expression is auto-regulated by a negative feedback mechanism. Northern blot analysis indicated that there are relatively higher levels of myostatin mRNA in the biceps femoris muscle of cattle that express a non- functional myostatin allele (Belgian Blue) as compared to normal cattle. In contrast, addition of exogenous myostatin decreases endogenous myostatin mRNA. Consistent with this result, wild type myostatin protein is able to repress myostatin promoter activity via Activin type IIb receptor (ActRIIB) and ALK5 (P < 0.001). However, non-functional myostatin (Piedmontese) failed to repress the myostatin promoter suggesting that myostatin auto-regulates its promoter by negative feedback inhibition. Auto-regulation by myostatin appears to be signaled through Smad7, since the expression of the inhibitory Smad7 is induced by myostatin and the over-expression of Smad7 in turn inhibits the myostatin promoter activity (P < 0.001). In contrast down regulation of Smad7 by siRNA results in increased myostatin mRNA indicating that Smad7 is a negative regulator of myostatin gene expression. Consistent with these results, a decrease in Smad7 mRNA and concomitant increase in myostatin expression is seen in myotubes that express non functional myostatin. In addition, interference with myostatin signaling prevents the induction of Smad7 promoter activity by myostatin. Based on these results, we propose that myostatin auto-regulates its gene expression through a Smad7 dependent mechanism in myogenic cells. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16110474     DOI: 10.1002/jcp.20477

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  39 in total

1.  SMAD7, an antagonist of TGF-beta signaling, is a candidate of prenatal skeletal muscle development and weaning weight in pigs.

Authors:  Chaoju Hua; Zishuai Wang; Jianbing Zhang; Xing Peng; Xinhua Hou; Yalan Yang; Kui Li; Zhonglin Tang
Journal:  Mol Biol Rep       Date:  2016-02-22       Impact factor: 2.316

2.  Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts.

Authors:  Xiaojia Ge; Craig McFarlane; Anuradha Vajjala; Sudarsanareddy Lokireddy; Zhi Hui Ng; Chek Kun Tan; Nguan Soon Tan; Walter Wahli; Mridula Sharma; Ravi Kambadur
Journal:  Cell Res       Date:  2011-04-19       Impact factor: 25.617

3.  Myostatin activation in patients with advanced heart failure and after mechanical unloading.

Authors:  Isaac George; Lawrence T Bish; Gayathri Kamalakkannan; Christopher M Petrilli; Mehmet C Oz; Yoshifumi Naka; H Lee Sweeney; Simon Maybaum
Journal:  Eur J Heart Fail       Date:  2010-03-27       Impact factor: 15.534

4.  The skeletal muscle satellite cell response to a single bout of resistance-type exercise is delayed with aging in men.

Authors:  Tim Snijders; Lex B Verdijk; Joey S J Smeets; Bryon R McKay; Joan M G Senden; Fred Hartgens; Gianni Parise; Paul Greenhaff; Luc J C van Loon
Journal:  Age (Dordr)       Date:  2014-08-10

5.  Estradiol in females may negate skeletal muscle myostatin mRNA expression and serum myostatin propeptide levels after eccentric muscle contractions.

Authors:  Darryn S Willoughby; Colin D Wilborn
Journal:  J Sports Sci Med       Date:  2006-12-15       Impact factor: 2.988

6.  Smad7 promotes and enhances skeletal muscle differentiation.

Authors:  Helen D Kollias; Robert L S Perry; Tetsuaki Miyake; Arif Aziz; John C McDermott
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

7.  Foxg1 promotes olfactory neurogenesis by antagonizing Gdf11.

Authors:  Shimako Kawauchi; Joon Kim; Rosaysela Santos; Hsiao-Huei Wu; Arthur D Lander; Anne L Calof
Journal:  Development       Date:  2009-03-18       Impact factor: 6.868

8.  Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.

Authors:  Kevin J Morine; Lawrence T Bish; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone.

Authors:  Jenny M Oldham; Claire C Osepchook; Ferenc Jeanplong; Shelley J Falconer; Kenneth G Matthews; John V Conaglen; David F Gerrard; Heather K Smith; Richard J Wilkins; James J Bass; Christopher D McMahon
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

Review 10.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.